Endothelin-converting enzyme-1 (ECE-1) is a downstream target of the homeobox transcription factor Nkx2-5¹.

Autor: Funke-Kaiser, H., Lemmer, J., Langsdorff, C. V., Thomas, A., Kovacevic, S. D., Strasdat, M., Behrouzi, T., Zollmann, F. S., Paul, M., Orzechowski, H.-D.

Publikováno v: FASEB Journal; Aug2003, Vol. 17 Issue 11, p1487, 3p, 2 Diagrams

Interleukin-1 receptor-associated kinase 4 (IRAK4) is a critical regulator of inflammatory signalling through toll-like receptors 4 and 7/8 in murine and human lungs.

Autor: Sayers I; Centre for Respiratory Research, NIHR Nottingham Biomedical Research Centre, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham, UK., Thakker D; Centre for Respiratory Research, NIHR Nottingham Biomedical Research Centre, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham, UK., Billington C; Centre for Respiratory Research, NIHR Nottingham Biomedical Research Centre, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham, UK., Kreideweiss S; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Grundl MA; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Bouyssou T; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Thamm S; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Kreuz S; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany., Hall IP; Centre for Respiratory Research, NIHR Nottingham Biomedical Research Centre, School of Medicine, Biodiscovery Institute, University of Nottingham, Nottingham, UK.

Publikováno v: British journal of pharmacology [Br J Pharmacol] 2024 Nov; Vol. 181 (22), pp. 4647-4657. Date of Electronic Publication: 2024 Aug 13.

Spironolactone mitigates, but does not reverse, the progression of renal fibrosis in a transgenic hypertensive rat.

Autor: Leader, Catherine J.¹ (AUTHOR), Kelly, Darren J.² (AUTHOR), Sammut, Ivan A.³ (AUTHOR), Wilkins, Gerard T.¹ (AUTHOR), Walker, Robert J.¹ (AUTHOR) rob.walker@otago.ac.nz

Publikováno v: Physiological Reports. May2020, Vol. 8 Issue 10, p1-13. 13p.

Novel therapeutic targets for the treatment of heart failure.

Autor: Tamargo, Juan¹ jtamargo@med.ucm.es, López-Sendón, José², López-Sendón, José (AUTHOR)

Publikováno v: Nature Reviews Drug Discovery. Jul2011, Vol. 10 Issue 7, p536-555. 20p. 9 Diagrams, 1 Chart.

Synthesis of 1-Azaspiro[4.5]deca-1,3-dienes from N -Propargylic β-Enaminones in Basic Medium.

Autor: Karadeniz, Eda, Zora, Metin

Publikováno v: Synthesis; 2019, Vol. 51 Issue 10, p2157-2170, 14p